Testing effectiveness (Phase 2)WithdrawnNCT00578591What this trial is testingRituximab for GVHDWho this might be right forGraft vs Host DiseaseAlogenic Hematopoietic Transplant Baylor College of Medicine
Not applicableUnknownNCT05723224What this trial is testingElective Endoscopic Gallbladder Treatment: Pilot StudyWho this might be right forCholecystolithiasisCholecystitis, Chronic Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Large-scale testing (Phase 3)WithdrawnNCT00349518What this trial is testingStudy of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALLWho this might be right forChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia Bristol-Myers Squibb
Very early researchUnknownNCT04285424What this trial is testingFMT for Steroid Resistant Gut Acute GVHDWho this might be right forStem Cell Transplant ComplicationsAcute Graft-Versus-Host DiseaseFecal Microbiota Transplantation Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableUnknownNCT05692713What this trial is testingPolyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)Who this might be right forChronic Graft-versus-Host-DiseaseAllogeneic Hematopoietic Stem Cell TransplantationLeukemia+2 more University of British Columbia 320
Testing effectiveness (Phase 2)Looking for participantsNCT06619561What this trial is testingEvaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)Who this might be right forChronic Graft-Versus-Host Disease (cGVHD) Deciphera Pharmaceuticals, LLC 48
Post-approval studies (Phase 4)Active Not RecruitingNCT06462469What this trial is testingStudy of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host DiseaseWho this might be right forSteroid-refractory Acute Graft Versus Host Disease Novartis Pharmaceuticals 36
Not applicableStudy completedNCT02316392What this trial is testingImaging and Understanding BOS in Lung TransplantationWho this might be right forBronchiolitis Obliterans Syndrome Children's Hospital Medical Center, Cincinnati 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05256537What this trial is testingFludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate MofetilWho this might be right forHematologic Neoplasms Ronald Paquette 60
Not applicableUnknownNCT05355675What this trial is testingThe Association of Microbiota Composition With cGVHD After Allo-HSCTWho this might be right forHematopoietic Stem Cell TransplantationHematologic MalignancyChronic Graft-versus-host-disease+1 more First Affiliated Hospital of Zhejiang University 300
Not applicableUnknownNCT04622475What this trial is testingEfficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHDWho this might be right forSteroid-refractory Gastrointestinal Acute Graft Versus Host Disease Nanfang Hospital, Southern Medical University 10
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Early research (Phase 1)Ended earlyNCT00376519What this trial is testingUmbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 3
Not applicableEnded earlyNCT00501228What this trial is testingTissue Repair in Stem Cell Transplant RecipientsWho this might be right forGraft-Versus-Host Disease M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Looking for participantsNCT05327023What this trial is testingDonor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesWho this might be right forHematologic Neoplasms National Cancer Institute (NCI) 430
Testing effectiveness (Phase 2)Study completedNCT02997280What this trial is testingRuxolitinib for Steroid-refractory GVHDWho this might be right forGraft Vs Host Disease St. Petersburg State Pavlov Medical University 75
Large-scale testing (Phase 3)Study completedNCT00114361What this trial is testing48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) InfectionWho this might be right forHepatitis B Foundation for Liver Research 138
Early research (Phase 1)Study completedNCT01371162What this trial is testingRO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis CWho this might be right forHepatitis C, Chronic, Healthy Volunteer Hoffmann-La Roche 42
Testing effectiveness (Phase 2)UnknownNCT05348096What this trial is testingEfficacy and Safety of Low-dose Ibrutinib and Itraconazole in Chronic Graft Versus Host DiseaseWho this might be right forChronic Graft-versus-host-disease Hospital Universitario Dr. Jose E. Gonzalez 13
Not applicableStudy completedNCT01422824What this trial is testingAn Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on HaemodialysisWho this might be right forAnemia, Kidney Disease, Chronic Hoffmann-La Roche 185